NCT05894395View on ClinicalTrials.gov

Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination

PHASE3RecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

March 1, 2025

Study Completion Date

September 1, 2025

Conditions

MumpsMeaslesRubella

Interventions

BIOLOGICAL

MMR booster vaccination (as M-M-R-VaxPro)

a single dose of MMR-containing vaccine (as M-M-R-VaxPro), in adults having previously received 2 lifetime doses of MMR-containing vaccine

Trial Locations (2)

8001

RECRUITING

Epidemiology, Biostatistics and Prevention Institute University of Zurich, Zurich

RECRUITING

Epidemiology, Biostatistics and Prevention Institute University of Zurich, Zurich

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Zurich

OTHER

NCT05894395 - Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination | Biotech Hunter | Biotech Hunter